City
Epaper

BA.5 Omicron subvariant 4 times more vaccine-resistant: Study

By IANS | Updated: July 16, 2022 04:40 IST

Los Angeles, July 16 The BA.5 Omicron subvariant, now the dominant coronavirus strain in the US, is four ...

Open in App

Los Angeles, July 16 The BA.5 Omicron subvariant, now the dominant coronavirus strain in the US, is four times more resistant to Covid-19 vaccines, according to a new study published in Nature.

The study found the variant is four times more resistant to messenger RNA vaccines than earlier strains of Omicron, which include Pfizer and Moderna Covid-19 vaccines, Xinhua news agency reported.

The strain is "hypercontagious" and is contributing to increases in hospitalisations and ICU admissions, said the Mayo Clinic in a report on Thursday.

The BA.5 strain represented 65 per cent of Covid-19 cases in the country in the week ending July 9, according to the latest data from the US Centers of Disease Control and Prevention.

Unvaccinated people have about a five times higher chance of contracting the virus than those who are vaccinated and boosted, while chances of hospitalisation are 7.5 times higher, and chances of death are 14 to 15 times higher, said Gregory Poland, Head of the Mayo Clinic's Vaccine Research Group.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: usXinhuaLos AngelesL.a.Los angeles dream centerPfizerPfizer inc.AngelesGregory polandPfizer india
Open in App

Related Stories

InternationalCalifornia: Man Sexually Assaults Woman Inside Los Angeles Whole Foods Market, CCTV Footage Surfaces

InternationalLaGuardia Airport Plane Accident: At Least 2 Killed, Several Injured After Air Canada Express CRJ-900 Collides With Fire Truck on Runway

InternationalLos Angeles Mass Stabbing: At Least 6 Injured in Knife Attack in Downtown LA

InternationalUS-Israel-Iran War: Japan, Germany, France Show Caution Over Trump’s Strait of Hormuz Warship Plan

InternationalUK Watchdogs Urge Social Media Giants To Stop Children Accessing Platforms

Health Realted Stories

HealthIndia to boost biosimilar insulin, CGM manufacturing as Global South looks for support

HealthIndia clocks unprecedented foodgrain output, boosts institutional support to farmers

HealthIndia tightens watch on GLP-1 drugs amid safety and misuse concerns

HealthIndia’s millet push receives dual boost at technology and grassroots levels

HealthUK heart rhythm expert now performing procedures in India